Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models

被引：97

作者：

Li, Yingjun ^{[1
,2
]}

Cao, Liu ^{[3
]}

Li, Ge ^{[4
]}

Cong, Feng ^{[4
]}

Li, Yunfeng ^{[4
]}

Sun, Jing ^{[5
]}

Luo, Yinzhu ^{[4
]}

Chen, Guijiang ^{[4
]}

Li, Guanguan ^{[1
]}

Wang, Ping ^{[1
]}

Xing, Fan ^{[3
]}

Ji, Yanxi ^{[3
]}

Zhao, Jincun ^{[5
]}

Zhang, Yu ^{[4
]}

Guo, Deyin ^{[3
]}

Zhang, Xumu ^{[1
,2
]}

机构：

[1] Southern Univ Sci & Technol, Coll Sci, Dept Chem, Shenzhen Key Lab Small Mol Drug Discovery & Synth, Shenzhen 518055, Guangdong, Peoples R China

[2] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Medi X, Shenzhen 518055, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen 518107, Peoples R China

[4] Guangdong Lab Anim Monitoring Inst, Guangdong Prov Key Lab Lab Anim, Guangzhou 510663, Guangdong, Peoples R China

[5] Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou 510182, Guangdong, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2022年 / 65卷 / 04期

基金：

中国国家自然科学基金;

关键词：

ANTIVIRAL ACTIVITY; TISSUE-CULTURE; VIRUS; CORONAVIRUS; PRODRUG; MECHANISM; EFFICACY; GS-5734; EBOLA;

D O I：

10.1021/acs.jmedchem.0c01929

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The outbreak of coronavirus disease 2019 (COVID-19) has resulted in a global pandemic due to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the time of this manuscript's publication, remdesivir is the only COVID-19 treatment approved by the United States Food and Drug Administration. However, its effectiveness is still under question due to the results of the large Solidarity Trial conducted by the World Health Organization. Herein, we report that the parent nucleoside of remdesivir, GS-441524, potently inhibits the replication of SARS-CoV-2 in Vero E6 and other cell lines. Challenge studies in both an AAV-hACE2 mouse model of SARS-CoV-2 and in mice infected with murine hepatitis virus, a closely related coronavirus, showed that GS-441524 was highly efficacious in reducing the viral titers in CoV-infected organs without notable toxicity. Our results support that GS-441524 is a promising and inexpensive drug candidate for treating of COVID-19 and other CoV diseases.

引用

页码：2785 / 2793

页数：9

共 44 条

[1] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Agostini, Maria L.
Andres, Erica L.
Sims, Amy C.
Graham, Rachel L.
Sheahan, Timothy P.
Lu, Xiaotao
Smith, Everett Clinton
Case, James Brett
Feng, Joy Y.
Jordan, Robert
Ray, Adrian S.
Cihlar, Tomas
Siegel, Dustin
Mackman, Richard L.
Clarke, Michael O.
Baric, Ralph S.
Denison, Mark R.
[J]. MBIO, 2018, 9 (02):
[2] The ProTide Prodrug Technology: Where Next?
Alanazi, Ashwag S.
James, Edward
Mehellou, Youcef
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (01): : 2 - 5
[3] Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease
Avataneo, Valeria
de Nicolo, Amedeo
Cusato, Jessica
Antonucci, Miriam
Manca, Alessandra
Palermiti, Alice
Waitt, Catriona
Walimbwa, Stephen
Lamorde, Mohammed
di Perri, Giovanni
D'Avolio, Antonio
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1772 - 1777
[4] Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Yan
Yao, Lingsheng
Wei, Tao
Tian, Fei
Jin, Dong-Yan
Chen, Lijuan
Wang, Meiyun
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1406 - 1407
[5] Remdesivir for the Treatment of Covid-19-Final Report
Beigel, John H.
Tomashek, Kay M.
Dodd, Lori E.
Mehta, Aneesh K.
Zingman, Barry S.
Kalil, Andre C.
Hohmann, Elizabeth
Chu, Helen Y.
Luetkemeyer, Annie
Kline, Susan
de Castilla, Diego Lopez
Finberg, Robert W.
Dierberg, Kerry
Tapson, Victor
Hsieh, Lanny
Patterson, Thomas F.
Paredes, Roger
Sweeney, Daniel A.
Short, William R.
Touloumi, Giota
Lye, David Chien
Ohmagari, Norio
Oh, Myoung-don
Ruiz-Palacios, Guillermo M.
Benfield, Thomas
Faetkenheuer, Gerd
Kortepeter, Mark G.
Atmar, Robert L.
Creech, C. Buddy
Lundgren, Jens
Babiker, Abdel G.
Pett, Sarah
Neaton, James D.
Burgess, Timothy H.
Bonnett, Tyler
Green, Michelle
Makowski, Mat
Osinusi, Anu
Nayak, Seema
Lane, H. Clifford
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) : 1813 - 1826
[6] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Borba, Mayla Gabriela Silva
Val, Fernando Fonseca Almeida
Sampaio, Vanderson Souza
Alexandre, Marcia Almeida Araujo
Melo, Gisely Cardoso
Brito, Marcelo
Mourao, Maria Paula Gomes
Brito-Sousa, Jose Diego
Baia-da-Silva, Djane
Guerra, Marcus Vinitius Farias
Hajjar, Ludhmila Abrahao
Pinto, Rosemary Costa
Balieiro, Antonio Alcirley Silva
Pacheco, Antonio Guilherme Fonseca
Santos, James Dean Oliveira, Jr.
Naveca, Felipe Gomes
Xavier, Mariana Simao
Siqueira, Andre Machado
Schwarzbold, Alexandre
Croda, Julio
Nogueira, Mauricio Lacerda
Romero, Gustavo Adolfo Sierra
Bassat, Quique
Fontes, Cor Jesus
Albuquerque, Bernardino Claudio
Daniel-Ribeiro, Claudio-Tadeu
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinicius Guimaraes
[J]. JAMA NETWORK OPEN, 2020, 3 (04) : E208857
[7] Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Brown, Ariane J.
Won, John J.
Graham, Rachel L.
Dinnon, Kenneth H., III
Sims, Amy C.
Feng, Joy Y.
Cihlar, Tomas
Denison, Mark R.
Baric, Ralph S.
Sheahan, Timothy P.
[J]. ANTIVIRAL RESEARCH, 2019, 169
[8] Immunomodulatory Drugs in the Management of SARS-CoV-2
Burrage, Daniel R.
Koushesh, Soraya
Sofat, Nidhi
[J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
[9] Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
[10] Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides
Cho, Aesop
Saunders, Oliver L.
Butler, Thomas
Zhang, Lijun
Xu, Jie
Vela, Jennifer E.
Feng, Joy Y.
Ray, Adrian S.
Kim, Choung U.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2705 - 2707

← 1 2 3 4 5 →